|
-
andrepharma3
2025-3-14
-
87
0
|
|
-
andrepharma3
2025-3-14
-
101
0
|
|
-
andrepharma3
2025-3-14
-
105
0
|
|
-
andrepharma3
2025-3-14
-
101
0
|
|
-
andrepharma3
2025-3-14
-
101
0
|
|
-
andrepharma3
2025-3-14
-
115
0
|
|
-
andrepharma3
2025-3-14
-
100
0
|
|
-
andrepharma3
2025-3-14
-
106
0
|
|
-
andrepharma3
2025-3-14
-
108
0
|
|
-
andrepharma3
2025-3-14
-
94
0
|
|
-
andrepharma3
2025-3-14
-
95
0
|
|
-
andrepharma3
2025-3-14
-
111
0
|
|
-
andrepharma3
2025-3-14
-
96
0
|
|
-
andrepharma3
2025-3-14
-
106
0
|
|
-
andrepharma3
2025-3-14
-
107
0
|
|
-
andrepharma3
2025-3-14
-
125
0
|
|
-
andrepharma3
2025-3-14
-
94
0
|
|
-
andrepharma3
2025-3-14
-
93
0
|
|
-
andrepharma3
2025-3-14
-
102
0
|
|
-
andrepharma3
2025-3-14
-
92
0
|